SWM
INSM icon

SeaCrest Wealth Management’s Insmed INSM Stock Holding History

SeaCrest Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$2K – 2289
2018
Q2 		$2K Hold
100
– – ﹤0.01% 2006
2018
Q1 		$2K Hold
100
– – ﹤0.01% 1984
2017
Q4 		$3K Buy
+100
New +$2.95K ﹤0.01% 1928

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

SeaCrest Wealth Management's INSM Position: Q3 2018 in Review

SeaCrest Wealth Management sold out of Insmed (INSM) in Q3 2018, closing a stake of 100 shares — an estimated $2K sold.

SeaCrest Wealth Management first reported a position in INSM in Q4 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

  • SeaCrest Wealth Management reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
  • SeaCrest Wealth Management sold 100 Insmed shares in Q3 2018, an estimated $2K.
  • SeaCrest Wealth Management first reported a position in Insmed in Q4 2017 and held it in 3 quarters.
  • SeaCrest Wealth Management's Insmed position peaked at $3K in Q4 2017.
  • 123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on SeaCrest Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.